The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
It's all a bit cloak and daggers.
My current thinking is, forget what could have been, use this as a full reset and if I believe Veative is heading in the right direction then I'll keep my shares and even buy more if the auction price comes out pretty low (which is almost certain in the first month with many wanting to get some cash back).
When there's blood on the streets.......
It is indeed.
I'd like to know the min unit quantity and/or revenue value though
Hmmm, just tried again. Failure notice, sorry we were unable to deliver......
Note, the email address to register interest for the online presentation doesn't work, bounces back as failed.
Good start hey
Cancellation effective from 8am Wed 18th!
Quite a detailed description of the Asset Matching Trading Facility
I'm still angry and no way to vent.
Indeed!
"The data are unequivocal".....
".......significant, therapeutic levels....."
I'd be very happy with anything approaching 300Million
All this talk of hope is just wishful thinking and completely futile I'm afraid.
Nothing good is coming our way for a long, long time. Background positivity is better than deterioration of the company but that's all folks
CA increased his stake who is obviously well informed when it comes to DEV / Veative, however, is this connected? who knows
Just tried a sell order, you never know:
'That security is not tradeable or does not exist'
I'm approx 20 miles from Wetherby and 10 miles from the Wetherby Whaler. Do I need to wear a white coat?
As above, no chance you'll be able to keep them in an ISA I'm afraid
10p? What would that value us at, over half a billion? Never going to happen
Lets get over the 1p hurdle first, hopefully sometime this year
The last update said Phase 1 expansion has provided more capacity than originally anticipated with revenue potential for over c. $40m which is c. $10m or c. 33% more than previously stated. As a result, the Phase 2 expansion has been pushed out to 2025.
I'm certainly happy with the est' $40 Million revenue potential of the Phase 1 expansion, in the short term
Systemzero 'is that £200 a share surely not ?....I was thinking £2 a share max..?'
£200ExC (SP banter from yesteryear) £2 max (I'd advise a little research may help you with that one)
Not expecting Phase 2 expansion until 2025 now
Looking back at the previous update; reduced losses, efficiencies realised, new products, increased capacity, operational flexibility, commercial growth in BioRinse & dCELL® business together with rebounding markets.......
I'm cautiously confident of a great 2023 (would be very much welcomed with the state of the markets just now)
Re-noting:
* The cash position for the Group as at 30.06.22 was $6.2m
* The operating loss for the six months 30.06.22 reduced to $1.3m & adjusted EBITDA loss reduced to $0.5m
* Phase 1 expansion has provided more capacity than originally anticipated with revenue potential for over
c. $40m which is c. $10m or c. 33% more than previously stated. As a result, the Phase 2 expansion has been pushed out to 2025.
That would be nice, I'd settle for 20p :D